Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
Identification of suitable reference genes for peripheral blood mononuclear cell subset studies in multiple sclerosis.
Assessing possible selection bias in a national voluntary MS longitudinal study in Australia.
Multiple Sclerosis: Improved Identification of Disease-relevant Changes in Gray and White Matter Using Susceptibility-based MR Imaging.
Cecal Ligation and Puncture Results in Long-Term Central Nervous System Myeloid Inflammation.
Characterizing cognitive function during relapse in multiple sclerosis.
Identification of a novel mechanism of action of fingolimod (FTY720) on human effector T cell function through TCF-1 upregulation.
Angiotensin IV is Induced in Experimental Autoimmune Encephalomyelitis but Fails to Influence the Disease.
The association of alcohol consumption and smoking with quality of life, disability and disease activity in an international sample of people with multiple sclerosis.
Mortality and comorbidities in patients with multiple sclerosis compared with a population without multiple sclerosis: An observational study using the US Department of Defense administrative claims database.
Role of TNF in mast cell neuroinflammation and pain.
Hexosylceramides as intrathecal markers of worsening disability in multiple sclerosis.
Simvastatin reduces the expression of adhesion molecules in circulating monocytes from hypercholesterolemic patients.
Resident glial cell activation in response to perispinal inflammation leads to acute changes in nociceptive sensitivity: implications for the generation of neuropathic pain.
The costs of disorders of the brain in Switzerland: an update from the European Brain Council Study for 2010.
Assessing the safety of biologic agents in patients with rheumatoid arthritis.
A PheWAS approach in studying HLA-DRB1*1501.
Control of IL-17 receptor signaling and tissue inflammation by the p38α-MKP-1 signaling axis in a mouse model of multiple sclerosis.
Immunotherapy using LPS-stimulated Bone Marrow-derived Dendritic Cells to Treat Experimental Autoimmune Encephalomyelitis.
Natural killer cells in human autoimmune disorders.
Risk factors for idiopathic optic neuritis recurrence.
Erratum to "Methodology of an International Study of People with Multiple Sclerosis Recruited through Web 2.0 Platforms: Demographics, Lifestyle, and Disease Characteristics"
Multiple sclerosis in 2012: Novel therapeutic options and drug targets in MS.
Response to letter regarding article 'Fingolimod effects on left ventricular function in multiple sclerosis'.
CX3CR1 in multiple sclerosis.
[Clinical significance of the cardiovascular effects of fingolimod treatment in multiple sclerosis].
Pages
« first
‹ previous
…
331
332
333
334
335
336
337
338
339
…
next ›
last »